B Vitamins and Cognitive Function — What the Research Shows
You are doing everything right. You slept seven hours, drank water, got outside. And yet the report in front of you might as well be written in smoke. You read a sentence, understand each word individually, and reach the end with nothing. You lose the thread of a conversation halfway through someone else's point. You sit down to write an email and forget what you were going to say before your fingers reach the keyboard.
It is not laziness. It is not age, not yet. It might not even be stress. It might be something your blood work has never flagged — because the thresholds it uses were not designed with your brain in mind.
What B Vitamins Actually Do Inside Your Brain
The B vitamin family includes eight distinct molecules, but three of them dominate the neuroscience: vitamin B12 (cobalamin), vitamin B6 (pyridoxine), and folate (B9). They do not work independently. They interlock in a set of biochemical cycles that, together, sustain the two things your brain cannot function without — intact wiring and a steady supply of chemical messengers.
B12 builds and maintains the wiring. Vitamin B12 is a required cofactor for the synthesis of myelin, the fatty sheath that insulates nerve fibres and allows electrical signals to travel quickly between brain regions. Faster myelin means faster processing speed. A 2024 study published in Brain Communications confirmed what neuroimaging researchers had long suspected: more highly myelinated white matter tracts are directly associated with faster cognitive processing speed across the adult lifespan. B12 is not the only input myelin needs, but without it, the insulation degrades and signals slow down.
B6 manufactures the messengers. Pyridoxal-5'-phosphate, the active form of B6, serves as a cofactor for aromatic L-amino acid decarboxylase — the enzyme responsible for the final biosynthetic step in producing serotonin, dopamine, and norepinephrine. It is also essential for the synthesis of GABA, the brain's primary inhibitory neurotransmitter. These four molecules between them regulate mood, motivation, attention, sleep, and the ability to dampen neural noise so you can focus. B6 does not just nudge their production. It is the enzymatic bottleneck. Without adequate B6, the production line stalls.
Folate powers the methylation cycle. Folate is the entry point for one-carbon metabolism — a set of interconnected cellular reactions that produce S-adenosylmethionine (SAM), the universal methyl donor the brain uses for DNA methylation, histone modification, and the synthesis of phospholipids, neurotransmitters, and myelin components. When folate is low, SAM production drops, and the downstream effects cascade across every system that depends on methylation — which, in the brain, is nearly everything.
These three vitamins converge at a single metabolic junction: the conversion of homocysteine to methionine. B12 acts as the cofactor for the enzyme that catalyses the reaction. Folate donates the methyl group. B6 handles the alternative disposal pathway. When any of the three falls short, homocysteine accumulates in the blood — and that accumulation has consequences the brain cannot ignore.
How Common Is B Vitamin Deficiency in Adults
More common than most clinicians screen for.
A systematic review of community-dwelling older adults in developed Western countries found that 29% to 35% had inadequate folate intake, 24% to 31% were low in vitamin B6, and 31% to 41% were short on riboflavin (B2). These are dietary shortfall figures. The biochemical picture is worse.
Vitamin B12 deficiency is estimated to affect 10% to 15% of people over 60 by standard serum measurements. But those measurements may be misleading. NHANES data from the United States found that when the cutoff was set at 200 pg/mL, roughly 3% of adults appeared deficient. Raise it to 346 pg/mL — a threshold many researchers now consider more appropriate for brain health — and the figure climbs to nearly 26%.
For B6, CDC analysis of 2003 to 2006 NHANES data found that over 10% of the US population had plasma pyridoxal-5'-phosphate levels below 20 nmol/L, indicating deficiency. Among adults over 60, that figure rose to 16%. Among women using oral contraceptives but not taking B6 supplements, three quarters were deficient.
The diagnostic gap is the real problem. Standard blood panels do not routinely measure B6 or folate in adults. B12 is checked more often, but the conventional "normal" range may be set too low to protect the brain — a point that a landmark 2025 study from UCSF made disturbingly clear.
Why "Normal" B12 Levels May Not Protect Your Brain
In 2025, Alexandra Beaudry-Richard and senior author Ari Green of the UCSF Departments of Neurology and Ophthalmology published a study in Annals of Neurology that challenged assumptions about what constitutes adequate B12 status. They enrolled 231 healthy older adults with no dementia or cognitive impairment, with a median B12 concentration of 414.8 pmol/L — well within the conventional normal range.
The findings were striking. Participants with lower levels of holotranscobalamin — the biologically active fraction of B12 — showed delayed visual evoked potentials, meaning electrical signals travelled more slowly through their visual processing pathways. They performed worse on cognitive processing speed tests. And their MRI scans revealed larger volumes of white matter hyperintensities — areas of structural brain injury associated with cognitive decline, dementia, and stroke risk.
"Our work shows what appear to be multiple negative effects for some people when their B12 levels are in the lower range of what has long been considered adequate or normal. This includes slowed transmission of signals in the brain, slowed processing speed on cognitive tests and MRI evidence of white matter injury." — Ari Green, UCSF
The same year, Francesca Marino and colleagues published a longitudinal analysis of 1,994 participants from the Framingham Heart Study. Using a composite B12 biomarker rather than simple serum levels, they found that participants in the highest B12 quartile had significantly slower rates of decline in memory, executive function, and language compared with those in the lowest quartile. The effect was not limited to the clinically deficient. It tracked across the normal range.
These studies suggest that for brain health, the question is not whether you are deficient by conventional standards. It is whether your levels are high enough to support the specific cognitive systems you rely on every day.
The Homocysteine Connection — What the Oxford Trial Found
When B12, B6, and folate are all adequate, they keep homocysteine levels low. When any of them drops, homocysteine rises. And elevated homocysteine is one of the most consistent biochemical risk factors for cognitive decline in the epidemiological literature.
A meta-analysis of prospective studies found that for every 5 micromol/L increase in homocysteine, the risk of dementia increased by 50%. Elevated homocysteine has been associated with brain atrophy, hippocampal volume loss, white matter damage, and the accumulation of amyloid-beta — the protein plaques that characterise Alzheimer's disease.
The most important intervention trial on this question came from Oxford. The VITACOG trial, led by A. David Smith and Helga Refsum as part of the Oxford Project to Investigate Memory and Ageing (OPTIMA), randomised 168 older adults with mild cognitive impairment to receive either a combination of folic acid (0.8 mg), vitamin B12 (0.5 mg), and vitamin B6 (20 mg) daily, or placebo, for two years.
The B vitamin group showed a 30% reduction in homocysteine levels. Across the entire treatment group, the rate of brain atrophy slowed by 29.6% compared with placebo. But the headline finding was in the subgroup with the highest baseline homocysteine levels: in those participants, B vitamin treatment reduced the rate of brain shrinkage by 53%. Atrophy of the medial temporal lobe — the region most vulnerable in Alzheimer's disease — was reduced by almost ninefold.
A subsequent Bayesian analysis confirmed the causal chain: B vitamins lowered homocysteine, which slowed brain atrophy, which slowed cognitive decline. The effect was not a statistical artefact. It was a mechanistic pathway.
If you have read our piece on how omega-3 fatty acids support brain structure, the connection deepens further. A follow-up analysis of the VITACOG data found that the B vitamin treatment was most effective in participants who also had adequate omega-3 status. In those with low omega-3 levels, the B vitamins had little effect on atrophy. The two nutrients appear to work synergistically — B vitamins managing the biochemistry of methylation, omega-3 providing the structural lipids that methylation acts upon.
Which Cognitive Systems B Vitamin Status Shapes
Population-level averages mask the specificity of what B vitamins actually affect. When you look through the lens of cognitive profiling rather than a single summary score, the picture sharpens.
Memory and sequencing is the dimension most directly vulnerable to B vitamin status. Working memory — the ability to hold, order, and manipulate information in real time — depends on rapid, high-fidelity communication across fronto-parietal circuits. That communication speed is a function of myelin integrity, which is a function of B12 availability. When B12 drops, myelination suffers, processing speed falls, and the working memory system that sits on top of it degrades. The Framingham data showed this clearly: B12 status predicted the rate of decline in memory and executive function over years. If you frequently forget what you just read, the problem may not be attention. It may be that the substrate your working memory runs on is operating below capacity.
Attention and rhythm — the system that regulates what your brain attends to, for how long, and how smoothly it shifts between tasks — is shaped by B6 through its control over dopamine and norepinephrine synthesis. Dopamine is not just a reward chemical. It is the neuromodulator that sets the gain on attentional circuits, determining how strongly relevant signals are amplified and irrelevant ones are suppressed. When B6 is low and dopamine production drops, the gain falls, and attention becomes diffuse, unstable, and harder to direct. A 2021 study published in Translational Psychiatry demonstrated that B6 deficiency hyperactivates the noradrenergic system, producing social deficits and cognitive impairment in animal models — a finding that mirrors the restless, unfocused attention profile many B6-deficient adults describe.
Emotional regulation — the capacity to manage emotional intensity and transition smoothly between affective states — also depends on B6, through both serotonin and GABA. Serotonin governs mood stability. GABA provides the inhibitory counterweight that prevents emotional reactions from overwhelming cognitive function. When B6 is insufficient to support the synthesis of both, emotional responses become more volatile, more persistent, and harder to modulate. If you have read our piece on emotional dysregulation, you will recognise the pattern — and the way it compounds the effects of attention and memory difficulties when multiple dimensions are compromised simultaneously.
The convergence matters. B vitamin deficiency does not produce a single symptom. It degrades the shared biochemical infrastructure that memory, attention, and emotional regulation all depend on. The result is a diffuse impairment that looks like stress, feels like ageing, and gets attributed to everything except the nutritional substrate it actually reflects.
If you have noticed this pattern in iron deficiency or vitamin D and brain fog, the underlying logic is the same. Nutritional shortfalls do not announce themselves with a single clear signal. They erode the foundation that multiple cognitive systems share.
What You Can Do About Your B Vitamin Status
The practical steps are straightforward, but they depend on knowing where you stand.
Get tested beyond the basics. Ask for serum B12, holotranscobalamin (the active fraction), methylmalonic acid (a functional marker of B12 sufficiency), plasma homocysteine, and serum folate. Standard B12 alone is not enough — the UCSF data showed that damage can occur well within the conventional normal range.
Eat the food first. B12 is found almost exclusively in animal products — meat, fish, eggs, dairy. Vegans and vegetarians are at elevated risk and should supplement. B6 is widespread in poultry, fish, potatoes, chickpeas, and bananas. Folate is richest in dark leafy greens, legumes, and fortified grains. But cooking, processing, and soil depletion all reduce the amounts that actually reach your plate.
Supplement strategically, not blindly. The VITACOG trial used specific doses — 0.8 mg folic acid, 0.5 mg B12, 20 mg B6 — that produced measurable brain protection over two years. These are well above standard dietary recommendations but within the safe upper limits. If your homocysteine is elevated, the evidence for supplementation is strong. If it is not, the evidence is weaker but the risk of supplementation is low.
Map your cognitive baseline. Understanding which cognitive dimensions are strongest and weakest in your own profile gives you a framework for interpreting changes over time. Tools like CognitionType can help you build that baseline — not as a diagnosis, but as a map of how your particular brain processes information across the dimensions that B vitamin status most directly affects.
Do not assume symptoms are psychological. The fog, the forgetfulness, the emotional volatility — these can all have a nutritional component that standard screening misses. The gap between clinical deficiency and optimal brain function is wide, and most adults sit somewhere in it without knowing.
The research is clear on one point: B vitamins are not optional extras for brain function. They are structural requirements. And the gap between what most adults consume and what their brains actually need is larger than almost anyone realises.
CognitionType is an informational cognitive assessment, not a clinical diagnosis. If you suspect a vitamin deficiency or a specific cognitive condition, we encourage you to seek formal evaluation from a qualified healthcare provider.